Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

被引：0
作者：
Shintaro Narita
Norihiko Tsuchiya
Teruaki Kumazawa
Shinya Maita
Kazuyuki Numakura
Takashi Obara
Hiroshi Tsuruta
Mitsuru Saito
Takamitsu Inoue
Yohei Horikawa
Shigeru Satoh
Hiroshi Nanjyo
Tomonori Habuchi
机构：
[1] Akita University School of Medicine,Department of Urology
[2] Senboku General Hospital,Department of Urology
[3] Akita University School of Medicine,Department of Pathology
来源：
World Journal of Surgical Oncology | / 10卷
关键词：
chemohormonal therapy; prostate cancer; docetaxel; estramustine phosphate; complete androgen blockade; androgen deprivation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 115 条
[1]  
Jemal A(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96
[2]  
Siegel R(1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Jama 280 969-974
[3]  
Ward E(1998)Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results J Urol 160 2428-2434
[4]  
Hao Y(2009)A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma Cancer Treat Rev 35 9-17
[5]  
Xu J(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 1502-1512
[6]  
Murray T(2004)Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N Engl J Med 351 1513-1520
[7]  
Thun MJ(2004)Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer Urology 63 1138-1142
[8]  
D'Amico AV(2005)Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer Clin Cancer Res 11 5233-5240
[9]  
Whittington R(2007)Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer BJU Int 100 274-280
[10]  
Malkowicz SB(2008)Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer J Urol 180 565-570
12345678910